Nobananas - the only thing management have done 'badly' is misjudge when the scoping study would be due. Initially they thought end of Jan, now most likely it will be March.
I for one think they have done a brilliant job – look at what they have achieved in the last 6 months. I am also confident we won’t see a CR until post release of scoping study.
If one is in NMR for the odd pip down or up then I can see why one might be disappointed but the fundamentals haven’t changed since the last ANN.
Some perspective is needed. My opinion only.
NMR Price at posting:
4.2¢ Sentiment: Buy Disclosure: Held
